Editorial: NK cell defects: diagnosis and treatment

Snehal Shabrish; Shanmuganathan Chandrakasan; Manisha Madkaikar

doi:10.3389/fimmu.2023.1323793

Editorial: NK cell defects: diagnosis and treatment

Front Immunol. 2023 Oct 31:14:1323793. doi: 10.3389/fimmu.2023.1323793. eCollection 2023.

Authors

Snehal Shabrish^{1

2}, Shanmuganathan Chandrakasan³, Manisha Madkaikar⁴

Affiliations

¹ Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
² Homi Bhabha National Institute, Mumbai, India.
³ Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States.
⁴ Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, King Edward Memorial (KEM) Hospital, Mumbai, Maharashtra, India.

No abstract available

Keywords: Fanconi anemia; NK cell; NK cell based therapeutics; NK cell biology; NK cell degranulation defects; NK cell-related gene signature; familial hemophagocytic lymphohistiocytosis.

Publication types

Editorial

MeSH terms

Killer Cells, Natural*
Membrane Proteins*

Substances

Membrane Proteins

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.